MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) are pleased to provide the presentation which will be delivered by its Chief Financial Officer, Jim Hallam and Michael Curtis, MMJ Non-Executive Director and Director of Embark Ventures Inc at the forthcoming Openbriefing
PAC Partners Equity Research has released its latest research and valuation report on Anatara Lifesciences (ASX:ANR). The report provided a SPEC BUY rating and a 12-month price target of $0.90 per share.
Following a recent investment from MMJ (ASX:MMJ), Australian hemp & cannabinoid brand, Hemple, has launched in the USA.
MMJ Group Holdings Ltd (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail.
Cann Global Limited (ASX:CGB) is pleased to advise that the company is in the process of providing the ASX with all the paperwork confirming completion of all the transactions, completion of all the share issues, receipt of all the required escrow agreements, and the related required relisting documentation.
MMJ Group Holdings Limited (ASX:MMJ)(ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) is pleased to announce it will be hosting a live audio webcast of the Investor Conference Call on 17 July 2019.
THC Global Group Limited (ASX:THC)(OTCMKTS:HDRPF) is pleased to advise that the Company's wholly owned subsidiary, THC Pharma Pty Ltd, has been granted a Manufacture Licence from the Australian Office of Drug Control for its Southport Manufacturing Facility.
